Your browser doesn't support javascript.
loading
Structure-activity Relationship of Indomethacin Derivatives as IDO1 Inhibitors.
Obata, Tohru; Shiratani, Sara; Nada, Tomomi; Kasaya, Yayoi; Arisawa, Mitsuhiro; Shuto, Satoshi; Tanaka, Motohiro.
Affiliation
  • Obata T; School of Pharmacy, Aichi Gakuin University, Nagoya, Japan; tobata@dpc.agu.ac.jp.
  • Shiratani S; School of Pharmacy, Aichi Gakuin University, Nagoya, Japan.
  • Nada T; Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
  • Kasaya Y; Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
  • Arisawa M; Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
  • Shuto S; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.
  • Tanaka M; Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Anticancer Res ; 41(5): 2287-2296, 2021 May.
Article in En | MEDLINE | ID: mdl-33952454

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Structure-Activity Relationship / Indomethacin / Enzyme Inhibitors / Indoleamine-Pyrrole 2,3,-Dioxygenase Limits: Humans Language: En Journal: Anticancer Res Year: 2021 Document type: Article Country of publication: Grecia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Structure-Activity Relationship / Indomethacin / Enzyme Inhibitors / Indoleamine-Pyrrole 2,3,-Dioxygenase Limits: Humans Language: En Journal: Anticancer Res Year: 2021 Document type: Article Country of publication: Grecia